Application 075199
- Type
- ANDA
- Sponsor
- ANI PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PENTOXIFYLLINE | PENTOXIFYLLINE | TABLET, EXTENDED RELEASE;ORAL | 400MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075199-001 | PENTOXIFYLLINE | PENTOXIFYLLINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 1999-09-03 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A075199-001 | PENTOXIFYLLINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 1999-09-03 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A075199-001 | PENTOXIFYLLINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 1999-09-03 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A075199-001 | PENTOXIFYLLINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 1999-09-03 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A075199-001 | PENTOXIFYLLINE | 400MG | TABLET, EXTENDED RELEASE / ORAL | 1999-09-03 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pentoxifylline | PENTOXIFYLLINE | Rising Pharma Holdings, Inc. | cd840a2c-2a0e-4b2b-84ff-a0406bb6fa37 | 2026-05-15 | Adverse reactions | Pentoxifylline PENTOXIFYLLINE |
| Pentoxifylline | PENTOXIFYLLINE | ANI Pharmaceuticals, Inc. | 9ca79c97-e4e5-4297-85eb-7a9b3d8083b5 | 2025-11-07 | Adverse reactions | Pentoxifylline PENTOXIFYLLINE |
| PENTOXIFYLLINE | PENTOXIFYLLINE | Major Pharmaceuticals | 59c9a583-1f93-480f-879c-457a574374da | 2025-09-22 | Adverse reactions | PENTOXIFYLLINE PENTOXIFYLLINE |
| PENTOXIFYLLINE | PENTOXIFYLLINE | Bryant Ranch Prepack | 84816505-9253-41cf-8894-2b2d0e4aff67 | 2025-09-04 | Adverse reactions | PENTOXIFYLLINE PENTOXIFYLLINE |
| Pentoxifylline | PENTOXIFYLLINE | Bryant Ranch Prepack | c3ad4fb4-8995-46ab-86e9-7ec67ef607f9 | 2025-04-07 | Adverse reactions | Pentoxifylline PENTOXIFYLLINE |
| Pentoxifylline | PENTOXIFYLLINE | NCS HealthCare of KY, LLC dba Vangard Labs | bd2f2672-62cd-4e77-8b0b-782f5d06198b | 2024-10-22 | Adverse reactions | Pentoxifylline PENTOXIFYLLINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 53808-0757 | Pentoxifylline | PENTOXIFYLLINE | State of Florida DOH Central Pharmacy | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 8560 | ORIG | 1999-09-03 |